Last week, the Trump administration imposed 100% tariffs on patented pharmaceutical products and ingredients. Imports of pharmaceuticals from China are largely generics, though, and may not feel much impact from these tariffs.

You don't have access to this post on China Trade Monitor at the moment, but if you upgrade your account you'll be able to see the whole thing, as well as all the other posts in the archive! Subscribing only takes a few seconds and will give you immediate access.

This post is for subscribers only

Subscribe now
Section 232TariffsPharmaceuticalsTrump Administration